Catalyst Wire Dossier Catalyst Wire Dossier

ASP0777

· Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP0777, covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil [Phase 1]

See pricing